Skip to main content
Huaiyao Peng on Muck Rack

Huaiyao Peng

As seen in: Wiley Online Library, ACS Publications, BioRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Huaiyao

Contact Huaiyao, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Nanofiber Length Shapes Vaccine Immunity: Mechanistic Insights from M13 Bacteriophage Click to copy article link Article link copied!

|
By Shengnan Huang, Allison Madow, Huaiyao Peng
| ACS Publications
Cite Jump to ExpandCollapse LetterJune 17, 2026 Nanofiber Length Shapes Vaccine Immunity: Mechanistic Insights from M13 Bacteriophage Click to copy article linkArticle link copied! Shengnan Huang Shengnan Huang The David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States Allison Madow Allison Madow The David H.
Open in Who Shared Issue with article?

A Programmable Nanovaccine Platform Based on M13 Bacteriophage for Personalized Cancer Vaccine and Therapy

|
By Shengnan Huang, Yanpu He, Allison Madow, Huaiyao Peng
| Wiley Online Library Verified
1 Introduction Cancer vaccines represent a groundbreaking advancement in both cancer immunotherapy and disease prevention, offering transformative potential in the fight against cancer.
Open in Who Shared Issue with article?

Reprogramming the genome of M13 bacteriophage for all-in-one personalized cancer vaccine

|
By Shengnan Huang, Yanpu He, Allison Madow, Huaiyao Peng
| BioRxiv
Abstract Peptide-based vaccines face limitations in immunogenicity and stability, and challenges in co-delivering antigens and adjuvants effectively. Virus-based nanoparticles, particularly M13 bacteriophage, present a promising solution due to their genetic modifiability, intrinsic adjuvanticity, and efficient antigen presentation capabilities. Here we developed a programmable M13 phage-based personalized cancer vaccine enabling single-step antigen-adjuvant assembly.
Open in Who Shared Issue with article?
See all 3 articles